pBK-CMV

Dual eukaryotic and prokaryotic expression vector.

Sequence Author: Agilent Technologies

|Download SnapGene Viewer
No matches
SfiI (4099) BseRI (4055) StuI (4050) PluTI (3872) SfoI (3870) NarI (3869) KasI (3868) MscI (3789) PflFI - Tth111I (3752) BsrDI (3640) RsrII (3352) BstBI (3187) PfoI (3091) BsaI (2878) ApaLI (2263) DraIII (240) MluI (463) BtsI - BtsαI (516) HpaI (590) MfeI (599) BclI * (692) PvuI (852) Acc65I (1015) KpnI (1019) TspMI - XmaI (1024) AleI - SmaI (1026) BstXI (1028) PspOMI (1042) ApaI (1046) NotI - SacII (1049) XbaI (1056) ScaI (1064) PaeR7I - XhoI (1068) HindIII (1074) EcoRI (1083) BamHI (1092) SpeI (1098) SalI (1104) AccI (1105) PstI - SbfI (1114) BssHII (1116) Eco53kI (1124) SacI (1126) NheI (1300) BmtI (1304) SnaBI (1555) NdeI (1659) AseI (1886) PciI (1949) pBK-CMV 4518 bp
SfiI  (4099)
1 site
G G C C N N N N N G G C C C C G G N N N N N C C G G

Efficient cleavage requires at least two copies of the SfiI recognition sequence.
Sticky ends from different SfiI sites may not be compatible.
BseRI  (4055)
1 site
G A G G A G ( N ) 8 N N C T C C T C ( N ) 8

Sticky ends from different BseRI sites may not be compatible.
BseRI quickly loses activity at 37°C.
Prolonged incubation with BseRI may lead to degradation of the DNA.
StuI  (4050)
1 site
A G G C C T T C C G G A
PluTI  (3872)
1 site
G G C G C C C C G C G G

Efficient cleavage requires at least two copies of the PluTI recognition sequence.
SfoI  (3870)
1 site
G G C G C C C C G C G G
NarI  (3869)
1 site
G G C G C C C C G C G G

Efficient cleavage requires at least two copies of the NarI recognition sequence.
KasI  (3868)
1 site
G G C G C C C C G C G G
MscI  (3789)
1 site
T G G C C A A C C G G T
PflFI  (3752)
1 site
G A C N N N G T C C T G N N N C A G

The 1-base overhangs produced by PflFI may be hard to ligate.
Sticky ends from different PflFI sites may not be compatible.
Tth111I  (3752)
1 site
G A C N N N G T C C T G N N N C A G

The 1-base overhangs produced by Tth111I may be hard to ligate.
Sticky ends from different Tth111I sites may not be compatible.
BsrDI  (3640)
1 site
G C A A T G N N C G T T A C

Sticky ends from different BsrDI sites may not be compatible.
RsrII  (3352)
1 site
C G G W C C G G C C W G G C

Efficient cleavage requires at least two copies of the RsrII recognition sequence.
Sticky ends from different RsrII sites may not be compatible.
For full activity, add fresh DTT.
BstBI  (3187)
1 site
T T C G A A A A G C T T
PfoI  (3091)
1 site
T C C N G G A A G G N C C T

Sticky ends from different PfoI sites may not be compatible.
BsaI  (2878)
1 site
G G T C T C N C C A G A G N ( N ) 4

Sticky ends from different BsaI sites may not be compatible.
BsaI can be used between 37°C and 50°C.
ApaLI  (2263)
1 site
G T G C A C C A C G T G
DraIII  (240)
1 site
C A C N N N G T G G T G N N N C A C

Sticky ends from different DraIII sites may not be compatible.
MluI  (463)
1 site
A C G C G T T G C G C A
BtsI  (516)
1 site
G C A G T G N N C G T C A C
BtsαI  (516)
1 site
G C A G T G N N C G T C A C

Sticky ends from different BtsαI sites may not be compatible.
HpaI  (590)
1 site
G T T A A C C A A T T G
MfeI  (599)
1 site
C A A T T G G T T A A C
BclI  (692)
1 site
T G A T C A A C T A G T
* Blocked by Dam methylation.
BclI is typically used at 50-55°C, but is 50% active at 37°C.
PvuI  (852)
1 site
C G A T C G G C T A G C
Acc65I  (1015)
1 site
G G T A C C C C A T G G
KpnI  (1019)
1 site
G G T A C C C C A T G G
TspMI  (1024)
1 site
C C C G G G G G G C C C
XmaI  (1024)
1 site
C C C G G G G G G C C C

Cleavage may be enhanced when more than one copy of the XmaI recognition sequence is present.
AleI  (1026)
1 site
C A C N N N N G T G G T G N N N N C A C
SmaI  (1026)
1 site
C C C G G G G G G C C C

SmaI can be used at 37°C for brief incubations.
BstXI  (1028)
1 site
C C A N N N N N N T G G G G T N N N N N N A C C

Sticky ends from different BstXI sites may not be compatible.
PspOMI  (1042)
1 site
G G G C C C C C C G G G
ApaI  (1046)
1 site
G G G C C C C C C G G G

ApaI can be used between 25°C and 37°C.
NotI  (1049)
1 site
G C G G C C G C C G C C G G C G
SacII  (1049)
1 site
C C G C G G G G C G C C

Efficient cleavage requires at least two copies of the SacII recognition sequence.
XbaI  (1056)
1 site
T C T A G A A G A T C T
ScaI  (1064)
1 site
A G T A C T T C A T G A
PaeR7I  (1068)
1 site
C T C G A G G A G C T C

PaeR7I does not recognize the sequence CTCTCGAG.
XhoI  (1068)
1 site
C T C G A G G A G C T C
HindIII  (1074)
1 site
A A G C T T T T C G A A
EcoRI  (1083)
1 site
G A A T T C C T T A A G
BamHI  (1092)
1 site
G G A T C C C C T A G G

After cleavage, BamHI-HF® (but not the original BamHI) can remain bound to DNA and alter its electrophoretic mobility.
SpeI  (1098)
1 site
A C T A G T T G A T C A
SalI  (1104)
1 site
G T C G A C C A G C T G
AccI  (1105)
1 site
G T M K A C C A K M T G

Efficient cleavage with AccI requires ≥13 bp on each side of the recognition sequence.
Sticky ends from different AccI sites may not be compatible.
PstI  (1114)
1 site
C T G C A G G A C G T C
SbfI  (1114)
1 site
C C T G C A G G G G A C G T C C
BssHII  (1116)
1 site
G C G C G C C G C G C G

BssHII is typically used at 50°C, but is 75% active at 37°C.
Eco53kI  (1124)
1 site
G A G C T C C T C G A G
SacI  (1126)
1 site
G A G C T C C T C G A G
NheI  (1300)
1 site
G C T A G C C G A T C G
BmtI  (1304)
1 site
G C T A G C C G A T C G
SnaBI  (1555)
1 site
T A C G T A A T G C A T
NdeI  (1659)
1 site
C A T A T G G T A T A C

Prolonged incubation with NdeI may lead to removal of additional nucleotides.
AseI  (1886)
1 site
A T T A A T T A A T T A
PciI  (1949)
1 site
A C A T G T T G T A C A

PciI is inhibited by nonionic detergents.
NeoR/KanR
3206 .. 4000  =  795 bp
264 amino acids  =  29.0 kDa
Product: aminoglycoside phosphotransferase from Tn5
confers resistance to neomycin, kanamycin, and G418 (Geneticin®)
NeoR/KanR
3206 .. 4000  =  795 bp
264 amino acids  =  29.0 kDa
Product: aminoglycoside phosphotransferase from Tn5
confers resistance to neomycin, kanamycin, and G418 (Geneticin®)
ori
2010 .. 2598  =  589 bp
high-copy-number ColE1/pMB1/pBR322/pUC origin of replication
ori
2010 .. 2598  =  589 bp
high-copy-number ColE1/pMB1/pBR322/pUC origin of replication
f1 ori
7 .. 462  =  456 bp
f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis
f1 ori
7 .. 462  =  456 bp
f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis
lacZα
797 .. 1183  =  387 bp
128 amino acids  =  14.7 kDa
Product: LacZα fragment of β-galactosidase
lacZα
797 .. 1183  =  387 bp
128 amino acids  =  14.7 kDa
Product: LacZα fragment of β-galactosidase
SV40 promoter
4035 .. 4392  =  358 bp
SV40 enhancer and early promoter
SV40 promoter
4035 .. 4392  =  358 bp
SV40 enhancer and early promoter
CMV enhancer
1532 .. 1835  =  304 bp
human cytomegalovirus immediate early enhancer
CMV enhancer
1532 .. 1835  =  304 bp
human cytomegalovirus immediate early enhancer
CMV promoter
1328 .. 1531  =  204 bp
human cytomegalovirus (CMV) immediate early promoter
CMV promoter
1328 .. 1531  =  204 bp
human cytomegalovirus (CMV) immediate early promoter
SV40 poly(A) signal
469 .. 590  =  122 bp
SV40 polyadenylation signal
SV40 poly(A) signal
469 .. 590  =  122 bp
SV40 polyadenylation signal
AmpR promoter
4394 .. 4498  =  105 bp
AmpR promoter
4394 .. 4498  =  105 bp
HSV TK poly(A) signal
2927 .. 2974  =  48 bp
herpesvirus thymidine kinase polyadenylation signal
HSV TK poly(A) signal
2927 .. 2974  =  48 bp
herpesvirus thymidine kinase polyadenylation signal
lac operator
1203 .. 1219  =  17 bp
The lac repressor binds to the lac operator to inhibit transcription in E. coli. This inhibition can be relieved by adding lactose or isopropyl-β-D-thiogalactopyranoside (IPTG).
lac operator
1203 .. 1219  =  17 bp
The lac repressor binds to the lac operator to inhibit transcription in E. coli. This inhibition can be relieved by adding lactose or isopropyl-β-D-thiogalactopyranoside (IPTG).
SV40 ori
4049 .. 4184  =  136 bp
SV40 origin of replication
SV40 ori
4049 .. 4184  =  136 bp
SV40 origin of replication
MCS
1015 .. 1127  =  113 bp
multiple cloning site
MCS
1015 .. 1127  =  113 bp
multiple cloning site
T7 promoter
975 .. 993  =  19 bp
promoter for bacteriophage T7 RNA polymerase
T7 promoter
975 .. 993  =  19 bp
promoter for bacteriophage T7 RNA polymerase
T3 promoter
1140 .. 1158  =  19 bp
promoter for bacteriophage T3 RNA polymerase
T3 promoter
1140 .. 1158  =  19 bp
promoter for bacteriophage T3 RNA polymerase
M13 fwd
952 .. 968  =  17 bp
common sequencing primer, one of multiple similar variants
M13 fwd
952 .. 968  =  17 bp
common sequencing primer, one of multiple similar variants
M13 rev
1179 .. 1195  =  17 bp
common sequencing primer, one of multiple similar variants
M13 rev
1179 .. 1195  =  17 bp
common sequencing primer, one of multiple similar variants
ORF:  2747 .. 2980  =  234 bp
ORF:  77 amino acids  =  8.6 kDa
ORF:  3155 .. 3691  =  537 bp
ORF:  178 amino acids  =  19.8 kDa
ORF:  3442 .. 3828  =  387 bp
ORF:  128 amino acids  =  14.6 kDa
ORF:  2736 .. 3185  =  450 bp
ORF:  149 amino acids  =  16.3 kDa
ORF:  797 .. 1183  =  387 bp
ORF:  128 amino acids  =  14.7 kDa
ORF:  3206 .. 4000  =  795 bp
ORF:  264 amino acids  =  29.0 kDa
Click here to try SnapGene

Download pBK-CMV.dna file

SnapGene

SnapGene is the easiest way to plan, visualize and document your everyday molecular biology procedures

  • Fast accurate construct design for all major molecular cloning techniques
  • Validate sequenced constructs using powerful alignment tools
  • Customize plasmid maps with flexible annotation and visualization controls
  • Automatically generate a rich graphical history of every edit and procedure

SnapGene Viewer

SnapGene Viewer is free software that allows molecular biologists to create, browse, and share richly annotated sequence files.

  • Gain unparalleled visibility of your plasmids, DNA and protein sequences
  • Annotate features on your plasmids using the curated feature database
  • Store, search, and share your sequences, files and maps

The maps, notes, and annotations in the zip file on this page are copyrighted material. This material may be used without restriction by academic, nonprofit, and governmental entities, except that the source must be cited as ’’www.snapgene.com/resources’’. Commercial entities must contact GSL Biotech LLC for permission and terms of use.

Discover the most user-friendly molecular biology experience.